Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fluoride-mediated tooth enamel remineralization refers to the biochemical process by which fluoride ions interact with demineralized tooth enamel to convert hydroxyapatite into fluorapatite, a mineral phase that is less soluble and more resistant to acid attack. This process helps repair early lesions of dental caries before cavitation and enhances the hardness and acid-resistance of enamel. The topical use of fluoride—via water fluoridation, toothpastes, mouthrinses, and varnishes—has been extensively demonstrated to (1) inhibit demineralization, (2) promote remineralization, and (3) exhibit mild antibacterial actions against caries-causing bacteria. Fluoride is not a receptor, transporter, or enzyme, and tooth enamel is not a molecular target in the classical sense, but rather a tissue substrate; thus, this is not considered a conventional therapeutic target like a receptor or enzyme but instead denotes a tissue-level mechanism of action for caries prevention and dental health.[1][2][3][5][6][7][8] Further clarification: - The query as stated ("Tooth enamel remineralization via fluoride ion") refers to a process, not a molecular target such as a receptor, enzyme, or transporter; thus, it is not a therapeutic "target" in pharmacological terms and should be classified as "is_target: false" and "is_incorrect: true" per conventions 5 and 11. - The true molecular target, if required for drug-action mapping, would be "Tooth enamel hydroxyapatite" as the substrate for fluoride action. Fluoride does not bind a discrete protein or classical molecular target but instead effects physicochemical modification of the mineralized matrix.
Formation of fluorapatite in enamel by exchange of hydroxyl groups in hydroxyapatite with fluoride ions; enhancement of remineralization and inhibition of demineralization by forming a more acid-resistant mineral phase; inhibition of bacterial metabolism by interfering with glycolytic enzymes[1][2][3][7][8]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tooth enamel (fluoride-mediated remineralization).